Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of peptidomimetics and enzyme inhibitors. Its structure supports the construction of chiral molecules with high stereochemical control, making it valuable in asymmetric synthesis. Commonly employed in solid-phase peptide synthesis due to the Fmoc (fluorenylmethyloxycarbonyl) protecting group, which allows for mild deprotection conditions. The bromo substituent provides a site for further functionalization via cross-coupling reactions such as Suzuki or Heck reactions, enabling the introduction of complex side chains in drug design.